Simons says: The Tipline for 29 January 2021

Outgoing Federal Trade Commission chair Joseph Simons is not a man of many words, but he is a man of many decisive votes. The agency squeezed out one more monopolisation case this week before Simons left his virtual office for the very last time. In the final Tipline of the FTC’s Simons era, GCR USA explores the agency’s challenge to a second reverse-payment settlement between Endo Pharmaceuticals and Impax Laboratories and takes a glance at the origins of the Department of Justice’s automakers emissions probe.

Unlock unlimited access to all Global Competition Review content